Albert Kim

Albert is a senior research associate, in mRNA technology at Verve Therapeutics. Prior to joining Verve, Albert worked as a senior research associate at Revitope Oncology, where he researched immunotherapy drugs, and bi-specific antibodies for solid tumors. He gained research experience as a senior research support associate at MIT in chemistry, where he studied class Ia and Class Ib ribonucleotide reductase (RNR). He received his Master of Science in medical sciences from Boston University.